• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Surveillance and Biometrics (OSB) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Data is current as of September 30, 2013

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent
Oct 20128593
Nov 20128591
Dec 20128592
Jan 20138594
Feb 20138588
Mar 20138593
Apr 20138585
May 20138592
Jun 20138588
Jul 20138595
Aug 20138588
Sep 20138594

FY 2013 Overall: 91%

Number of OSB intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A264
Nov 2012N/A230
Dec 2012N/A258
Jan 2013N/A331
Feb 2013N/A279
Mar 2013N/A323
Apr 2013N/A329
May 2013N/A338
Jun 2013N/A312
Jul 2013N/A337
Aug 2013N/A341
Sep 2013N/A327

FY 2013 Total: 3,684

Total number of OSB intra- and inter-Office eConsults completed during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A285
Nov 2012N/A254
Dec 2012N/A280
Jan 2013N/A354
Feb 2013N/A317
Mar 2013N/A349
Apr 2013N/A385
May 2013N/A369
Jun 2013N/A355
Jul 2013N/A354
Aug 2013N/A386
Sep 2013N/A347

FY 2013 Total: 3,050

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.